RANDAL J KIRK Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

RANDAL J KIRK in HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner, Director
Holdings: 4,120,689 shares
Latest Transaction: Aug 28 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RANDAL J KIRK in HALOZYME THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02256,8604,628,6171,897,6102.2 M to 1.9 M (-11.92 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2264,9961,184,2272,154,4702.2 M to 2.2 M (-2.93 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2061,4281,117,9902,219,4662.3 M to 2.2 M (-2.69 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02175,3893,160,5103,900,9194.1 M to 3.9 M (-4.30 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2244,381808,6224,076,3084.1 M to 4.1 M (-1.08 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2041,944763,3814,120,6894.2 M to 4.1 M (-1.01 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48149,3532,760,0432,280,8942.4 M to 2.3 M (-6.15 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49464,6248,126,2742,430,2472.9 M to 2.4 M (-16.05 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1595,8191,643,2962,894,8713 M to 2.9 M (-3.20 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48101,9821,884,6274,162,6334.3 M to 4.2 M (-2.39 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49317,2575,548,8254,264,6154.6 M to 4.3 M (-6.92 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1565,4271,122,0734,581,8724.6 M to 4.6 M (-1.41 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2456,668976,9562,985,0543 M to 3 M (-1.86 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1554,397932,9093,041,7223.1 M to 3 M (-1.76 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36180,1543,127,4733,096,1193.3 M to 3.1 M (-5.50 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2438,695667,1024,643,4514.7 M to 4.6 M (-0.83 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1537,144637,0204,682,1464.7 M to 4.7 M (-0.79 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36123,0142,135,5234,719,2904.8 M to 4.7 M (-2.54 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.08120,6062,059,9503,276,2733.4 M to 3.3 M (-3.55 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.48132,5912,317,6913,396,8793.5 M to 3.4 M (-3.76 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5287,1851,527,4813,529,4703.6 M to 3.5 M (-2.41 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.0882,3531,406,5894,842,3044.9 M to 4.8 M (-1.67 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.4890,5361,582,5694,924,6575 M to 4.9 M (-1.81 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5259,5331,043,0185,015,1935.1 M to 5 M (-1.17 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9029,074491,3513,616,6553.6 M to 3.6 M (-0.80 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3089,1361,542,0533,645,7293.7 M to 3.6 M (-2.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3261,7411,069,3543,734,8653.8 M to 3.7 M (-1.63 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9019,853335,5165,074,7265.1 M to 5.1 M (-0.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3060,8641,052,9475,094,5795.2 M to 5.1 M (-1.18 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3242,159730,1945,155,4435.2 M to 5.2 M (-0.81 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3421,710376,4515,299,3745.3 M to 5.3 M (-0.41 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3421,710376,4515,299,3745.3 M to 5.3 M (-0.41 %)
Jul 26 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.002,327,60302,327,6030 to 2.3 M
Jul 26 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.002,264,48305,321,0843.1 M to 5.3 M (+74.09 %)
Jul 26 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorSellJ0.006,328,853006.3 M to 0 (-100.00 %)
May 15 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorOption ExerciseM10.3710,000103,7000
May 15 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyM10.3710,000103,7003,562,3883.6 M to 3.6 M (+0.28 %)
May 08 2017GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorGrantA0.0014,13503,552,3883.5 M to 3.6 M (+0.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0021,858021,8580 to 21.9 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0065,572065,5720 to 65.6 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00131,1440131,1440 to 131.1 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.004,382046,70142.3 K to 46.7 K (+10.35 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0027,2600290,460263.2 K to 290.5 K (+10.36 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.002,23502,2350 to 2.2 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0023,2590354,653331.4 K to 354.7 K (+7.02 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0023,2590354,654331.4 K to 354.7 K (+7.02 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00372011,31710.9 K to 11.3 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00371,18603,056,6012.7 M to 3.1 M (+13.82 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0081,7950216,795135 K to 216.8 K (+60.59 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorSellJ0.001,326,320001.3 M to 0 (-100.00 %)
May 05 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorGrantA0.0020,20203,538,2533.5 M to 3.5 M (+0.57 %)
May 08 2015GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorGrantA0.0013,17503,518,0513.5 M to 3.5 M (+0.38 %)

Page:   1